COMBINATIONS (THIAMINE+PYRIDOXINE)100mg/50mg, INJ. SOL.

Auto-translated from ro

Original title: COMBINATII (THIAMINUM+PYRIDOXINUM)100mg/50mg, SOL. INJ

Institutul Regional de Oncologie Iasi

Published: Oct 28, 2026

Updated: Oct 28, 2026

Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Romania, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: ro

This tender, originating from Romania, concerns the supply of pharmaceutical products, specifically injections containing COMBINATIONS of THIAMINE (Vitamin B1) and PYRIDOXINE (Vitamin B6) at a concentration of 100mg/50mg per solution for injection. The contracting authority is looking to procure these medications in accordance with the specifications detailed in the tender's technical documentation (caietului de sarcini). The tender specifies minimum and maximum quantities required, indicating a need for flexible supply capabilities. Typical requirements for pharmaceutical tenders include adherence to strict quality standards (e.g., GMP - Good Manufacturing Practice), provision of product samples, detailed product information (including composition, expiry dates, and storage conditions), and proof of marketing authorization. Suppliers must demonstrate their ability to meet the specified quantities within defined delivery timelines and ensure the integrity of the cold chain if required. Compliance with national and European pharmaceutical regulations is essential. The objective is to ensure the availability of essential medications for healthcare provision.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on October 28, 2026. Last refreshed today. Original language: ro. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Institutul Regional de Oncologie Iasi

Institutul Regional de Oncologie Iasi has issued 65 procurement notices on BidsFactory, including 5 currently open and 37 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Romania. Notices are distributed via TED - Tenders Electronic Daily (EU) and SEAP Romania. Most recent publication: October 28, 2026.

Frequently asked questions about this tender

Who is the contracting authority?

This notice was issued by Institutul Regional de Oncologie Iasi in Romania. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Romania. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.